What is the current stock price of Cybin Inc. (CYBN)?

As of the latest market data, Cybin Inc. (CYBN) is trading at $8.28. The stock has seen a gain of 1.22% today.

Does Cybin Inc. (CYBN) pay a dividend?

Based on current data, Cybin Inc. does not have a confirmed active dividend policy.

What is the market cap of Cybin Inc.?

The current market capitalization of Cybin Inc. (CYBN) is approximately unavailable.

CYBN

Cybin Inc.·Healthcare

8.28

1.222%(+0.10)

Market Closed

8.50

2.657%(+0.22)

After Hours

Last Updated: — ET

52W L: $4.8152W H: $10.72

CYBN NEWS

seekingalpha.com

Mar 6

Cybin Inc. (HELP) Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder Prepared Remarks Transcript

Company Profile

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2019-09-13

Beta

0.79

Websitewww.cybin.com↗